Skip to main content

Elevai Labs Inc

For the period ended Jun 30, 2024. Filed Aug 14, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 14, 2024

ELAB$1.69+7.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 1. Financial Statements

Condensed Consolidated Financial Statements of

For the quarterly periods ended June 30, 2024, and 2023

(Unaudited - Expressed in United States Dollars)

Condensed Consolidated Balance Sheets

(Unaudited - Expressed in United States dollar)

As of:June 30, 2024December 31, 2023
ASSETS
Current Assets
Cash$100,034$3,326,851
Receivables, net29,07036,161
Prepaids and deposits923,4441,060,765
Inventory, net978,548495,667
Total Current Assets2,031,0964,919,444
Deposit10,77310,773
Property and equipment, net55,75153,119
Intangibles, net2,845,066-
Operating lease right-of-use asset137,535206,582
TOTAL ASSETS$5,080,221$5,189,918
LIABILITIES
Current Liabilities
Accounts payable and accrued liabilities$1,181,441$669,375
Customer deposits24,31436,693
Due to related parties173,64877,127
Current portion of consideration payable348,403-
Current portion of lease liability140,063145,000
Derivative liabilities67,355369,158
Total Current Liabilities1,935,2241,297,353
Consideration payable505,361-
Operating lease liability-65,489
TOTAL LIABILIITES$2,440,585$1,362,842
Commitments and Contingencies
EQUITY
Common stock, $0.0001 par value, 300,000,000 shares authorized; 18,892,115 and 17,329,615 shares issued and outstanding as of June 30, 2024, and December 31, 2023, respectively1,8891,733
Additional paid-in capital12,470,13610,849,031
Accumulated other comprehensive income1,242202
Accumulated deficit(9,833,631)(7,023,890)
TOTAL EQUITY2,639,6363,827,076
TOTAL LIABILITIES AND EQUITY$5,080,221$5,189,918

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited - Expressed in United States dollar)

Three months ended June 30, 2024Three months ended June 30, 2023Six months ended June 30, 2024Six months ended June 30, 2023
Revenue$605,529316,5301,220,092459,350
Cost of sales166,275108,180335,186152,613
Gross profit$439,254208,350884,906306,737
Expenses
Depreciation and amortization2,7092,8885,0935,385
Marketing and promotion721,489114,0511,114,527216,727
Consulting fees185,443149,723581,569233,687
Office and administrative663,956529,9501,542,564964,009
Professional fees158,143168,933338,065306,730
Investor relations6,37737,452104,62275,720
Research and development52,385133,654173,526217,395
Foreign exchange (gain) loss2442,3747852,633
Travel and entertainment57,121122,655116,229184,170
Total Expenses$1,847,8671,261,6803,976,9802,206,456
Net loss before other income (expense)$(1,408,613)(1,053,330)(3,092,074)(1,899,719)
Other income (expense)
Change in fair value of derivative liabilities26,864(222,468)301,803(459,246)
Interest expense(30,806)(4,409)(54,343)(7,045)
Interest income643491505,456
Other income--34,723-
Net loss$(1,412,491)(1,279,858)(2,809,741)(2,360,554)
Other comprehensive income (loss)
Currency translation adjustment(141)2621,040375
Total comprehensive loss$(1,412,632)(1,279,596)(2,808,701)(2,360,179)
Basic and diluted loss per share$(0.08)(0.128)(0.158)(0.240)
Weighted average shares outstanding18,298,5729,976,72517,814,0939,838,599

Condensed Consolidated Statements of Changes in Stockholders’ Equity

Series seed 1 preferred stock · Series seed 2 preferred stock · Series A preferred stock · Common Stock · Additional · Accumulated other
Number of sharesAmountNumber of sharesAmountNumber of sharesAmountNumber of sharesAmountpaid-in capitalAccumulated deficitcomprehensive incomeTotal
#$#$#$#$$$$$
Balance, April 1, 2023213,730213,635,2523641,861,7991869,880,9759884,714,674(3,803,069)224913,388
Private placement------107,86111323,578--323,589
Share-based compensation--------109,907--109,907
Net loss for the period---------(1,279,858)-(1,279,858)
Currency translation adjustment----------262262
Balance, June 30, 2023213,730213,635,2523641,861,7991869,988,8369995,148,159(5,082,927)48667,288
Balance, April 1, 2024------17,329,6151,73310,904,370(8,421,140)1,3832,486,346
Issued for acquisition of intangible assets------1,562,500156772,247--772,403
Obligation to issue stock for acquisition of intangible assets--------838,374--838,374
Share-based compensation--------(44,855)--(44,855)
Net loss for the period--------(1,412,491)-(1,412,491)
Currency translation adjustment----------(141)(141)
Balance, June 30, 2024------18,892,1151,88912,470,136(9,833,631)1,2422,639,636

Condensed Consolidated Statements of Changes in Stockholders’ Equity

Series seed 1 preferred stock · Series seed 2 preferred stock · Series A preferred stock · Common Stock · Additional · Accumulated other
Number of sharesAmountNumber of sharesAmountNumber of sharesAmountNumber of sharesAmountpaid-in capitalAccumulated deficitcomprehensive incomeTotal
#$#$#$#$$$$$
Balance, January 1, 2023213,730213,635,2523641,861,7991869,568,4759573,852,044(2,722,373)1111,131,310
Private placement------357,861361,073,553--1,073,589
Exercise of stock options------62,500637,494--37,500
Share-based compensation--------185,068--185,068
Net loss for the period---------(2,360,554)-(2,360,554)
Currency translation adjustment----------375375
Balance, June 30, 2023213,730213,635,2523641,861,7991869,988,8369995,148,159(5,082,927)48667,288
Balance, January 1, 2024------17,329,6151,73310,849,031(7,023,890)2023,827,076
Issued for acquisition of intangible assets1,562,500156772,247--772,403
Obligation to issue stock for acquisition of intangible assets--------838,374--838,374
Share-based compensation--------10,484--10,484
Net loss for the period---------(2,809,741)-(2,809,741)
Currency translation adjustment----------1,0401,040
Balance, June 30, 2024------18,892,1151,88912,470,136(9,833,631)1,2422,639,636

Condensed Consolidated Statements of Cash Flows

For the Six months ended June 30, 2024, and 2023

June 30, 2024 · June 30, 2023
Operating activities
Net loss$(2,809,741)$(2,360,554)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization45,9605,825
Share-based compensation10,484185,068
Straight-line rent expense(1,379)(1,378)
Change in fair value of derivative liabilities(301,803)459,246
Non-cash interest expense42,312-
R&D costs for intangible assets39,483-
Changes in operating assets and liabilities:
Receivables6,958(21,480)
Prepaid expenses and deposits137,295(183,518)
Inventory(482,881)(247,718)
Accounts payable and accrued liabilities210,111375,053
Customer deposits(12,379)75,194
Due to related parties50,30660,000
Cash flows used in operating activities$(3,104,757)$(1,654,262)
Investing activities
Purchase of equipment(9,160)(11,191)
Purchase of intangible assets(112,320)-
Cash flows used in investing activities$(121,480)$(11,191)
Financing activities
Exercise of stock options-37,500
Proceeds from issuance of common stock and warrants-1,073,589
Cash flows provided by financing activities$-$1,111,089
Effect of exchange rate changes on cash(580)728
Decrease in cash(3,226,817)(553,636)
Cash, beginning of period3,326,8511,154,901
Cash, ending of period$100,034$601,265
Supplemental cash flow information:
Cash paid for interest$11,104$4,898
Cash paid for taxes--
Non-cash Investing and Financing transactions:
Common stock issued and issuable on acquisition of intangible asset$772,247$-
Obligation to issue stock for acquisition of intangible assets$838,374$-
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.